Nachrichten zur Vertex Pharmaceuticals Aktie

Biotech Report: Pelosis Taiwan-Reise belastet Märkte, Evotec (EVT) gegen den Trend gesucht

Biotech-Aktien zeigen sich im deutschen Handel uneinheitlich. Papiere von Evotec und Biontech legen zu, während MorphoSys und BB Biotech…

Why Vertex Pharmaceuticals Stock Was Soaring Today

The companys popular Trikafta continues to boost the fundamentals....…

Vertex Pharmaceuticals (VRTX) Q2 2022 Earnings Call Transcript

VRTX earnings call for the period ending June 30, 2022....…

Vertex Pharmaceuticals (VRTX) Surpasses Q2 Earnings and Revenue Estimates

Vertex (VRTX) delivered earnings and revenue surprises of 3.45% and 3.02%, respectively, for the quarter ended June 2022. Do the…

Vertex Pharmaceuticals Lifts FY22 Product Revenue Outlook

CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - While reporting its results for the second quarter on Thursday, Vertex Pharmaceuticals Incorporated (VRTX) lifted its…

Will Vertex Pharmaceuticals Q2 results bring positive surprise?

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Top Analyst Reports for Johnson & Johnson, Cigna, & Vertex

Todays Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Cigna Corporation (CI), and…

If You Invested $5,000 in Vertex Pharmaceuticals in 2017, This Is How Much You Would Have Today

Your investment would have been a winning one....…

Zacks Investment Ideas feature highlights: Vertex Pharmaceuticals

Vertex Pharmaceuticals is part of the Zacks Investment Ideas article....…

What 8 Analyst Ratings Have To Say About Vertex Pharmaceuticals

Analysts have provided the following ratings for Vertex Pharmaceuticals (NASDAQ:VRTX) within the last quarter: Latest Ratings for VRTX …

Vertex (VRTX) to Buy ViaCyte to Speed Up VX-880 Program

Vertex (VRTX) will acquire ViaCyte for $320 million in cash....…

Vertex Pharmaceuticals (VRTX) Stock Moves -0.07%: What You Should Know

Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $294.07, moving -0.07% from the previous trading session....…

Vertex Pharmaceuticals: US-Biotechkonzern will ViaCyte übernehmen - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie…

Form 8-K VERTEX PHARMACEUTICALS For: Jul 09

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Thinking about trading options or stock in Advanced Micro Devices, UnitedHealth Group, Vertex Pharmaceuticals, Tesla, or Meta Platforms?

NEW YORK, July 8, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AMD, UNH, VRTX, TSLA, and META. Click…

Vertex Pharmaceuticals: Sprung auf neues Hoch in Sicht? Aktienanalyse

Kulmbach (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von "Der Aktionär": Martin Weiss, stellvertretender Chefredakteur vom Anlegermagazin "Der Aktionär", nimmt die Aktie des US-Biotechkonzerns…

Vertex (VRTX) VX-880 Early Study Sees Lifting of Clinical Hold

The FDA lifts clinical hold on Vertexs (VRTX) study on VX-880, its stem-cell-derived, fully differentiated islet replacement therapy that could…

Form 8-K VERTEX PHARMACEUTICALS For: Jul 01

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Vertex Pharma Says FDA Lifts Clinical Hold On Phase 1/2 Trial Of VX-880 To Treat Type 1 Diabetes

CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - Vertex Pharmaceuticals Inc. (VRTX) announced Tuesday that the U.S. Food and Drug Administration (FDA) has lifted…

Vertex: FDA Lifts Clinical Hold on VX-880 Study in Type 1 Diabetes >VRTX

Vertex: FDA Lifts Clinical Hold on VX-880 Study in Type 1 Diabetes >VRTX...…

2 Reasons to Buy Vertex Pharmaceuticals Now

The stock gained momentum in the first half....…

This Biopharmaceutical Company Has A Better 1-Year Return Than Tesla, Apple, Starbucks, Nvidia And Microsoft

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) creates new possibilities via medicine to cure diseases and improve peoples lives, and over the past…

Vertex Pharmaceuticals: Immer noch ein Kauf? - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von "Der Aktionär": Max Gross vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie…

+27 Prozent seit Jahresanfang: Dieser Wert schlägt den Markt um Längen!

Es gibt sie: Aktien, die trotz einer miserablen ersten Jahreshälfte gegen den Gesamtmarkttrend deutlich gestiegen sind. Mit einem Plus von…

Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know

Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $272.31, moving +0.79% from the previous trading session....…

Buy the Dip on These 3 Healthcare Stocks

Heres why our roundtable likes Vir Biotechnology, OrthoPediatrics, and Vertex Pharmaceuticals....…

$100 Invested In Vertex Pharmaceuticals 20 Years Ago Would Be Worth This Much Today

Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 20 years by 8.19% on an annualized basis producing an…

Vertex Pharmaceuticals (VRTX) Stock Moves -1.01%: What You Should Know

Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $250.96, moving -1.01% from the previous trading session....…

Vertex Pharmaceuticals: Kursziel erhöht

New York (www.aktiencheck.de) - Rating-Update: Philip Nadeau, Analyst von Cowen and Company, bewertet die Aktie des US-Biotechkonzerns Vertex Pharmaceuticals Inc. (ISIN:…

Vertex Pharmaceuticals: Neues Kursziel

New York (www.aktiencheck.de) - Rating-Update: Jasper Hellweg, Analyst von Argus Research, stuft die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN…

Vertex Pharmaceuticals (VRTX) Stock Moves -1.86%: What You Should Know

Vertex Pharmaceuticals (VRTX) closed at $254.88 in the latest trading session, marking a -1.86% move from the prior day....…

Vertex – Verschnaufpause im Aufwärtstrend

Die Aktie des Biopharmazie-Konzerns Vertex Pharmaceuticals Inc. (WKN: 882807) hatte nach einer zyklischen Zwischen-Baisse im vergangenen Oktober bei 176,36 USD einen Boden…

Vertex Pharma Gains FDA Breakthrough Therapy Designation For Kidney Disease Drug

Vertex Pharmaceuticals (NASDAQ: VRTX) received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for its drug candidate…

Vertex Pharma: FDA Grants Inaxaplin Breakthrough Therapy Designation

CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - Vertex Pharmaceuticals Incorporated (VRTX) announced the FDA has granted inaxaplin Breakthrough Therapy Designation for APOL1-mediated focal…

Vertex präsentiert neue Daten aus der klinischen Phase-1/2-Studie zu VX-880 bei den 82. Scientific Sessions der American Diabetes Association

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) legte heute weitere Daten zu Patienten vor, die in Teil A der klinischen Phase-1/2-Studie…

Vertex Pharmaceuticals upgraded to buy from hold at Maxim Group

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vertex Pharmaceuticals Incorporated - VRTX

NEW YORK , May 30, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Vertex Pharmaceuticals…

What 5 Analyst Ratings Have To Say About Vertex Pharmaceuticals

Over the past 3 months, 5 analysts have published their opinion on Vertex Pharmaceuticals (NASDAQ:VRTX) stock. These analysts are typically…

Form 8-K VERTEX PHARMACEUTICALS For: May 23

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Catalyst Biosciences Sells Complement Portfolio for $60 Million

SOUTH SAN FRANCISCO, Calif., May 23, 2022 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that…

The Zacks Analyst Blog Highlights Alibaba, McDonald, Advanced Micro Devices, Abbott Laboratories, and Vertex Pharmaceuticals

Alibaba, McDonald, Advanced Micro Devices, Abbott Laboratories, and Vertex Pharmaceuticals are part of the Zacks top Analyst Blog....…